行情

CORV

Correvio药业
CORV
NASDAQ
已退市
市盈率(FWD)
市销率
市净率
市值
-0.5284
0.5694
-27.8079
27,793,595.44
关于 CORV
Correvio Pharma Corp是一家加拿大的专业制药公司。该公司提供满足急性护理医师和患者需求的品牌。 该公司为医院内急性护理市场开发、收购和商业化品牌。以下是其批准和销售的品牌组合:用于治疗急性细菌性皮肤和皮肤结构感染(ABSSSI)的Xydalba;用于治疗社区获得性肺炎(CAP)和医院获得性肺炎(HAP)的头孢菌素抗生素Zevtera/Mabelio;用于将近期发作的心房颤动转换为窦性心律的Brinavess;用于减少急性冠状动脉综合征患者的血栓性心血管事件的Aggrastat;以及用于控制多个心血管适应症的快速心率的短效β受体阻滞剂的Esmocard和Esmocard Lyo。其候选产品包括提供曲前列环素的药物装置组合Trevyent。
展开

CORV 新闻

更多
Correvio Obtains Final Order for Plan of Arrangement
CNW Group · 05/21 21:01
Correvio Pharma Reports Obtained Final Order For Plan Of Arrangement For $76M
Benzinga · 05/21 20:03
Merger Arbitrage Mondays - A Large Number Of Rumored Deals But No Cigar
Seeking Alpha - Article · 05/18 13:35
Correvio Announces Results from Annual General and Special Meeting of Securityholders
CNW Group · 05/15 22:55
Will Correvio Pharma (CORV) Report Negative Q1 Earnings? What You Should Know
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 05/06 16:30
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
PR Newswire · 05/06 13:00
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
PR Newswire · 05/01 13:00
Correvio Reports ISS Recommends Shareholders Vote For Deal With ADVANZ PHARMA
Benzinga · 05/01 12:08

热门股票

代码
价格
涨跌幅

微牛提供Correvio药业(NASDAQ-CORV)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CORV股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CORV股票基本功能。